What Recursion Pharmaceuticals RXRX is doing that separates it from the herd 466 20260507 The key risks discussed in Zevia PBC ZVIA earnings Q1 2026 EPS Tops Views Why Lithium LAC deserves a deeper look right now Underperforming 20260508 UL Solutions Holds Near 100 as Cautious Optimism Persists